BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Miao LJ, Yan S, Zhuang QF, Mao QY, Xue D, He XZ, Chen JP. miR-106b promotes proliferation and invasion by targeting Capicua through MAPK signaling in renal carcinoma cancer. Onco Targets Ther 2019;12:3595-607. [PMID: 31190862 DOI: 10.2147/OTT.S184674] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu S, An G, Cao Q, Li T, Jia X, Lei L. The miR-106b/NR2F2-AS1/PLEKHO2 Axis Regulates Migration and Invasion of Colorectal Cancer through the MAPK Pathway. Int J Mol Sci 2021;22:5877. [PMID: 34070923 DOI: 10.3390/ijms22115877] [Reference Citation Analysis]
2 Liang H, Li L, Zhu S, Tan J, Yang B, Wang X, Wu G, Xie C, Li L, Liu Z, Li Y, Song H, Chen G, Lin L. MicroRNA-744-5p suppresses tumorigenesis and metastasis of osteosarcoma through the p38 mitogen-activated protein kinases pathway by targeting transforming growth factor-beta 1. Bioengineered 2022;13:12309-25. [PMID: 35593122 DOI: 10.1080/21655979.2022.2072619] [Reference Citation Analysis]
3 Dankert JT, Wiesehöfer M, Wach S, Czyrnik ED, Wennemuth G. Loss of RBMS1 as a regulatory target of miR-106b influences cell growth, gap closing and colony forming in prostate carcinoma. Sci Rep 2020;10:18022. [PMID: 33093529 DOI: 10.1038/s41598-020-75083-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Li R, Lu C, Li X, Chen X, Huang G, Wen Z, Li H, Tao L, Hu Y, Zhao Z, Chen Z, Lai Y. A Four-MicroRNA Panel in Serum as a Potential Biomarker for Screening Renal Cell Carcinoma. Front Genet 2022;13:897827. [DOI: 10.3389/fgene.2022.897827] [Reference Citation Analysis]
5 Yang F, Sun Z, Wang D, Du T. MiR-106b-5p regulates esophageal squamous cell carcinoma progression by binding to HPGD. BMC Cancer 2022;22:308. [PMID: 35317779 DOI: 10.1186/s12885-022-09404-8] [Reference Citation Analysis]
6 Sánchez-Maldonado JM, Collado R, Cabrera-Serrano AJ, Ter Horst R, Gálvez-Montosa F, Robles-Fernández I, Arenas-Rodríguez V, Cano-Gutiérrez B, Bakker O, Bravo-Fernández MI, García-Verdejo FJ, López JAL, Olivares-Ruiz J, López-Nevot MÁ, Fernández-Puerta L, Cózar-Olmo JM, Li Y, Netea MG, Jurado M, Lorente JA, Sánchez-Rovira P, Álvarez-Cubero MJ, Sainz J. Type 2 Diabetes-Related Variants Influence the Risk of Developing Prostate Cancer: A Population-Based Case-Control Study and Meta-Analysis. Cancers (Basel) 2022;14:2376. [PMID: 35625981 DOI: 10.3390/cancers14102376] [Reference Citation Analysis]
7 Sun H, Chen X. MiR-106b-5p Promotes Malignant Behaviors of Cervical Squamous Cell Carcinoma Cells by Targeting TIMP2. Reprod Sci 2021. [PMID: 34767243 DOI: 10.1007/s43032-021-00788-9] [Reference Citation Analysis]
8 Yang C, Dou R, Wei C, Liu K, Shi D, Zhang C, Liu Q, Wang S, Xiong B. Tumor-derived exosomal microRNA-106b-5p activates EMT-cancer cell and M2-subtype TAM interaction to facilitate CRC metastasis. Mol Ther 2021;29:2088-107. [PMID: 33571679 DOI: 10.1016/j.ymthe.2021.02.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Kim JW, Ponce RK, Okimoto RA. Capicua in Human Cancer. Trends Cancer 2021;7:77-86. [PMID: 32978089 DOI: 10.1016/j.trecan.2020.08.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]